The US has approved lenacapavir for HIV prevention. But experts worry that cuts to the health budget will 'squander' the drug ...

Congressional leaders celebrated the restored $20 million in previously frozen HIV prevention funds and surveillance programs ...

How will the Trump administration's cuts to HIV research impact the progress that's been made towards ending the epidemic in the U.S.?

No, Atlanta is not experiencing an outbreak of HIV, although the rates of new diagnosis are considered high in some ...

While Congress fails to stave off cuts to HIV care, community leaders in Mississippi and beyond race to limit the damage.

Giving people the option of a twice-a-year injectable is "a game changer, not only for the United States ... the HIV infection rate by 96% in groups of cisgender men and gender-diverse people in the U ...

Black people account for nearly 40% of those living with HIV in the U.S., according to the CDC. In the South, stigma and limits to health care access put people more at risk.

The US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a twice-yearly injectable drug developed for adults and teenagers.

Black people account for nearly 40% of those living with HIV in the U.S., according to the CDC. In the South, stigma and limits to health care access put people more at risk.